Finding new antibiotics from fungi
Discovering novel natural products from fungal species
This study is looking for new natural antibiotics from fungi to help fight infections that don't respond to regular treatments, and it's for anyone concerned about antibiotic resistance.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Chemia Biosciences, INC. NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10920019 on NIH RePORTER |
What this research studies
This research focuses on discovering novel natural products from fungal species to combat antibiotic resistance, a growing public health crisis. By utilizing advanced technologies like high-throughput mass spectrometry and genome mining, the team aims to identify new antibiotics that can effectively target resistant pathogens. The approach involves analyzing microbial cultures to predict the molecular products of biosynthetic gene clusters, which are responsible for producing natural antibiotics. This innovative methodology seeks to overcome the limitations of traditional antibiotic discovery techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections that are difficult to treat due to antibiotic resistance.
Not a fit: Patients with infections that are already effectively treated by existing antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively treat infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research has shown promise in discovering new antibiotics through innovative techniques, indicating that this approach could yield significant results.
Where this research is happening
Pittsburgh, United States
- Chemia Biosciences, INC. — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Behsaz, Bahar — Chemia Biosciences, INC.
- Study coordinator: Behsaz, Bahar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.